24.12.2012 Views

Annual Meeting Proceedings Part 1 - American Society of Clinical ...

Annual Meeting Proceedings Part 1 - American Society of Clinical ...

Annual Meeting Proceedings Part 1 - American Society of Clinical ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

222s Gastrointestinal (Colorectal) Cancer<br />

3577 General Poster Session (Board #31F), Mon, 8:00 AM-12:00 PM<br />

Is conversion to resection possible with hepatic arterial infusion (HAI) and<br />

systemic (SYS) even in previously treated patients (pts) with unresectable<br />

colorectal liver metastases (UnCLM)? Presenting Author: Nancy E. Kemeny,<br />

Memorial Sloan-Kettering Cancer Center, New York, NY<br />

Background: Previously, we showed thatHAI with FUDR � dexamethasone<br />

(Dex) plus SYS produced a 47 % resectability rate in a retrospective study<br />

<strong>of</strong> 49 pts with UnCLM. Methods: Prospectively evaluated UnCLM pts in a<br />

new protocol were combined with the above protocol (n�105 pts) and all<br />

were treated with HAI FUDR/Dex � Sys. Unresectability was defined as<br />

diffuse bilateral metastases, involvement <strong>of</strong> all hepatic/portal veins, and/or<br />

inability to preserve remaining liver with adequate perfusion. Factors<br />

associated with conversion were identified using a multivariate logistic<br />

regression model. Overall survival (OS) and progression free survival (PFS)<br />

were calculated from pump placement by the Kaplan-Meier method.<br />

Resectability was a time-dependent covariate in a Cox regression model.<br />

Results: 61 <strong>of</strong> the 105 pts had prior SYS (56 %with prior Oxali) and 45<br />

(74%) were progressing at the time <strong>of</strong> pump placement. In previously<br />

treated pts, 44% underwent resection, with a median OS <strong>of</strong> 45 mos. Of 44<br />

chemo-naïve pts, 57% underwent hepatectomy, with a median OS <strong>of</strong> 68<br />

mos. The following were significantly associated with resection conversion:<br />

lesion number [p�0.02], baseline CEA [p�0.04], females [p�0.03] and<br />

clinical risk score (CRS) [p�0.05]. In multivariate analysis, gender and<br />

CRS remained predictive <strong>of</strong> resectability. Surgery greatly reduced the<br />

hazard <strong>of</strong> death by 67% [HR: 0.33, 95%CI: 0.17-0.61, p�0.0004], after<br />

adjusting for several risk factors (Table). Median PFS was 12 mos for all<br />

pts. Conclusions: Even in previously treated pts,HAI � SYS is an approach<br />

to convert UnCLM to resection. Gender and CRS are associated with<br />

conversion to resectability.<br />

Multivariate Cox regression models.<br />

HR (95%CI) P value<br />

OS<br />

Surgery (yes vs no)* 0.33 (0.17-0.61) �0.001<br />

Gender (F vs M) 0.95 (0.51-1.77) 0.88<br />

CRS (>3vs3vs

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!